218 related articles for article (PubMed ID: 26342699)
1. Antifungal activity of 4-hydroxy-3-(3-methyl-2-butenyl)acetophenone against Candida albicans: evidence for the antifungal mode of action.
Soberón JR; Lizarraga EF; Sgariglia MA; Carrasco Juárez MB; Sampietro DA; Ben Altabef A; Catalán CA; Vattuone MA
Antonie Van Leeuwenhoek; 2015 Nov; 108(5):1047-57. PubMed ID: 26342699
[TBL] [Abstract][Full Text] [Related]
2. Antifungal activity and cytotoxicity of extracts and triterpenoid saponins obtained from the aerial parts of Anagallis arvensis L.
Soberón JR; Sgariglia MA; Pastoriza AC; Soruco EM; Jäger SN; Labadie GR; Sampietro DA; Vattuone MA
J Ethnopharmacol; 2017 May; 203():233-240. PubMed ID: 28389355
[TBL] [Abstract][Full Text] [Related]
3. The synthesis and synergistic antifungal effects of chalcones against drug resistant Candida albicans.
Wang YH; Dong HH; Zhao F; Wang J; Yan F; Jiang YY; Jin YS
Bioorg Med Chem Lett; 2016 Jul; 26(13):3098-3102. PubMed ID: 27210436
[TBL] [Abstract][Full Text] [Related]
4. Potent antifungal activity of extracts and pure compound isolated from pomegranate peels and synergism with fluconazole against Candida albicans.
Endo EH; Cortez DA; Ueda-Nakamura T; Nakamura CV; Dias Filho BP
Res Microbiol; 2010 Sep; 161(7):534-40. PubMed ID: 20541606
[TBL] [Abstract][Full Text] [Related]
5. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans.
Li Y; Chang W; Zhang M; Li X; Jiao Y; Lou H
FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25752309
[TBL] [Abstract][Full Text] [Related]
6. Investigating the antifungal activity and mechanism(s) of geraniol against Candida albicans strains.
Leite MC; de Brito Bezerra AP; de Sousa JP; de Oliveira Lima E
Med Mycol; 2015 Apr; 53(3):275-84. PubMed ID: 25480017
[TBL] [Abstract][Full Text] [Related]
7. Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans.
Calabrese EC; Castellano S; Santoriello M; Sgherri C; Quartacci MF; Calucci L; Warrilow AG; Lamb DC; Kelly SL; Milite C; Granata I; Sbardella G; Stefancich G; Maresca B; Porta A
J Antimicrob Chemother; 2013 May; 68(5):1111-9. PubMed ID: 23292344
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of anti-Candida potential of geranium oil constituents against clinical isolates of Candida albicans differentially sensitive to fluconazole: inhibition of growth, dimorphism and sensitization.
Zore GB; Thakre AD; Rathod V; Karuppayil SM
Mycoses; 2011 Jul; 54(4):e99-109. PubMed ID: 20337938
[TBL] [Abstract][Full Text] [Related]
9. Chitosan silver nanocomposite (CAgNC) as an antifungal agent against Candida albicans.
Kulatunga D; Dananjaya S; Godahewa GI; Lee J; De Zoysa M
Med Mycol; 2017 Feb; 55(2):213-222. PubMed ID: 27495320
[TBL] [Abstract][Full Text] [Related]
10. 2-Hydroxyphenacyl azoles and related azolium derivatives as antifungal agents.
Emami S; Foroumadi A; Falahati M; Lotfali E; Rajabalian S; Ebrahimi SA; Farahyar S; Shafiee A
Bioorg Med Chem Lett; 2008 Jan; 18(1):141-6. PubMed ID: 18032039
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model.
Lignell A; Löwdin E; Cars O; Sjölin J
J Antimicrob Chemother; 2008 Jul; 62(1):142-8. PubMed ID: 18408237
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo interactions between fluconazole and allicin against clinical isolates of fluconazole-resistant Candida albicans determined by alternative methods.
Guo N; Wu X; Yu L; Liu J; Meng R; Jin J; Lu H; Wang X; Yan S; Deng X
FEMS Immunol Med Microbiol; 2010 Mar; 58(2):193-201. PubMed ID: 19878317
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
14. Candida albicans biofilm inhibition by synergistic action of terpenes and fluconazole.
Pemmaraju SC; Pruthi PA; Prasad R; Pruthi V
Indian J Exp Biol; 2013 Nov; 51(11):1032-7. PubMed ID: 24416942
[TBL] [Abstract][Full Text] [Related]
15. In vitro assessment of the growth and plasma membrane H
Orie NN; Warren AR; Basaric J; Lau-Cam C; Piętka-Ottlik M; Młochowski J; Billack B
J Biochem Mol Toxicol; 2017 Jun; 31(6):. PubMed ID: 28151580
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
[TBL] [Abstract][Full Text] [Related]
17. Structural optimization of berberine as a synergist to restore antifungal activity of fluconazole against drug-resistant Candida albicans.
Liu H; Wang L; Li Y; Liu J; An M; Zhu S; Cao Y; Jiang Z; Zhao M; Cai Z; Dai L; Ni T; Liu W; Chen S; Wei C; Zang C; Tian S; Yang J; Wu C; Zhang D; Liu H; Jiang Y
ChemMedChem; 2014 Jan; 9(1):207-16. PubMed ID: 24376206
[TBL] [Abstract][Full Text] [Related]
18. Fungicidal effect of three new synthetic cationic peptides against Candida albicans.
Nikawa H; Fukushima H; Makihira S; Hamada T; Samaranayake LP
Oral Dis; 2004 Jul; 10(4):221-8. PubMed ID: 15196144
[TBL] [Abstract][Full Text] [Related]
19. Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle.
Zore GB; Thakre AD; Jadhav S; Karuppayil SM
Phytomedicine; 2011 Oct; 18(13):1181-90. PubMed ID: 21596542
[TBL] [Abstract][Full Text] [Related]
20. Novel hybrids of fluconazole and furanones: design, synthesis and antifungal activity.
Borate HB; Sawargave SP; Chavan SP; Chandavarkar MA; Iyer R; Tawte A; Rao D; Deore JV; Kudale AS; Mahajan PS; Kangire GS
Bioorg Med Chem Lett; 2011 Aug; 21(16):4873-8. PubMed ID: 21757344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]